This U.S. House bill would increase research and programs focused on bleeding disorders in underserved populations, especially women and girls. Introduced on May 13, 2026 by Ms. Johnson of Texas and others, it was referred to the House Committee on Energy and Commerce. The bill highlights long diagnosis delays, barriers to treatment, pregnancy risks, and the economic costs of heavy menstrual bleeding related to undiagnosed bleeding disorders.
This bill could change how federal money is spent on research and programs for bleeding disorders, which may affect residents who use federal health programs or services in Houston and across Texas.
